Use of ultraviolet-light irradiated multiple myeloma cells as immunogens to generate tumor-specific cytolytic T lymphocytes

Journal of Immune Based Therapies and Vaccines

Volumn 6, Issue , 2008, Pages

  Gullo, Charles A ^a,b   Hwang, William Y K ^a,b   Poh, Chye K ^b   Au, Melvin ^b   Cow, Geraline ^a,b   Teoh, Gerrard ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Singapore Health Services   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CELL ANTIGEN; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; GLUCOSE REGULATED PROTEIN 96; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90; MITOMYCIN; PROTEIN INHIBITOR; TUMOR CYTOTOXIC T LYMPHOCYTE VACCINE;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE ACTIVATION; MULTIPLE MYELOMA; MYELOMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR REJECTION; ULTRAVIOLET IRRADIATION; UPREGULATION;

EID: 44049098546     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-6-2     Document Type: Article

References (51)

1. Alajlan A Alfadley A Pedersen KT Transfer of vitiligo after allogeneic bone marrow transplantation J Am Acad Dermatol 2002, 46:606-610 10.1067/ mjd.2002.117215 11907519
2. Landis SH Murray T Bolden S Wingo PA Cancer statistics, 1998 CA Cancer J Clin 1998, 48:6-29 9449931
3. T.Y. L Gullo C Hwang W Teoh G The role of cytolytic T lymphocytes in the eridication of multiple myeloma SGH Proceedings 2004 ,13:106-112
4. Raitakari M Brown RD Gibson J Joshua DE T cells in myeloma Hematol Oncol 2003, 21:33-42 10.1002/hon.704 12605421
5. Ramakrishnan M Schonthal AH Lee AS Endoplasmic reticulum stress-inducible protein GRP94 is associated with an Mg2+-dependent serine kinase activity modulated by Ca2+ and GRP78/BiP J Cell Physiol 1997, 170:115-129 10.1002/ (SICI)1097-4652(199702)170:2<115::AID-JCP3>3.0.CO;2-R 9009140
6. Ransom JH Schengrund CL Bartlett GL Solubilization and partial characterization of a tumor-rejection antigen from an ultraviolet light-induced murine tumor Int J Cancer 1981, 27:545-554 10.1002/ ijc.2910270419 7275357
7. Andrew ME Braciale TJ Antigen-dependent proliferation of cloned continuous lines of H-2-restricted influenza virus-specific cytotoxic T lymphocytes J Immunol 1981, 127:1201-1204 6167621
8. Kedar E Weiss DW The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy Adv Cancer Res 1983, 38:171-287 6224401
9. Binder RJ Blachere NE Srivastava PK Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules J Biol Chem 2001, 276:17163-17171 10.1074/jbc.M011547200 11278929
10. Tamura Y Peng P Liu K Daou M Srivastava PK Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations Science 1997, 278:117-120 10.1126/science.278.5335.117 9311915
11. Gorelik E Begovic M Duty L Herberman RB Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor Cancer Res 1991, 51:1521-1528 1997193
12. Leemhuis T Wells S Scheffold C Edinger M Negrin RS A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma Biol Blood Marrow Transplant 2005, 11:181-187 10.1016/j.bbmt.2004.11.019 15744236
13. Taieb J Chaput N Menard C Apetoh L Ullrich E Bonmort M Pequignot M Casares N Terme M Flament C Opolon P Lecluse Y Metivier D Tomasello E Vivier E Ghiringhelli F Martin F Klatzmann D Poynard T Tursz T Raposo G Yagita H Ryffel B Kroemer G Zitvogel L A novel dendritic cell subset involved in tumor immunosurveillance Nat Med 2006, 12:214-219 10.1038/ nm1356 16444265
14. Suck G Novel approaches using natural killer cells in cancer therapy Semin Cancer Biol 2006, 16:412-418 10.1016/j.semcancer.2006.07.006 16914327
15. Rasmussen T Hansson L Osterborg A Johnsen HE Mellstedt H Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells Blood 2003, 101:4607-4610 10.1182/ blood-2002-06-1925 12576327
16. Nadler SG Tepper MA Schacter B Mazzucco CE Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins Science 1992, 258:484-486 10.1126/science.1411548 1411548
17. Hayashi T Hideshima T Anderson KC Novel therapies for multiple myeloma Br J Haematol 2003, 120:10-17 10.1046/j.1365-2141.2003.03929.x 12492571
18. Xu W Mimnaugh EG Kim JS Trepel JB Neckers LM Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2 Cell Stress Chaperones 2002, 7:91-96 514806 11892991 10.1379/ 1466-1268(2002)007<0091:HNGRTI>2.0.CO;2
19. Gullo CA Teoh G Heat shock proteins: To present or not, that is the question Immunol Lett 2004, 94:1-10 10.1016/j.imlet.2004.04.002 15234529
20. Redpath JL Sun C UVC-induced expression of a tumor-associated antigen in human cell hybrids (HeLa X skin fibroblasts): Repair of potentially lethal and potentially transforming damage Carcinogenesis 1989, 10:723-726 10.1093/carcin/10.4.723 2702721
21. Srivastava PK DeLeo AB Old LJ Tumor rejection antigens of chemically induced sarcomas of inbred mice Proc Natl Acad Sci U S A 1986, 83:3407-3411 323523 3458189 10.1073/pnas.83.10.3407
22. Schreiber KL Forman J Effect of graft-versus-host disease on anti-tumor immunity J Immunol 1990, 144:2018-2026 1968493
23. Sheikh MS Antinore MJ Huang Y Fornace AJ Jr. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1 Oncogene 1998, 17:2555-2563 10.1038/sj.onc.1202292 9840918
24. Suto R Srivastava PK A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides Science 1995, 269:1585-1588 10.1126/ science.7545313 7545313
25. Brunati AM Contri A Muenchbach M James P Marin O Pinna LA GRP94 (endoplasmin) co-purifies with and is phosphorylated by Golgi apparatus casein kinase FEBS Lett 2000, 471:151-155 10.1016/S0014-5793(00)01378-8 10767412
26. Massaia M Borrione P Battaglio S Mariani S Beggiato E Napoli P Voena C Bianchi A Coscia M Besostri B Peola S Stiefel T Even J Novero D Boccadoro M Pileri A Idiotype vaccination in human myeloma: Generation of tumor-specific immune responses after high-dose chemotherapy Blood 1999, 94:673-683 10397734
27. Ishii S Hiroishi K Eguchi J Mitamura K Dendritic cell maturation induced by delivery of ultraviolet-mediated apoptotic colorectal cancer cell lines Anticancer Res 2003, 23:2457-2463 12894528
28. Matzinger P The JAM test. A simple assay for DNA fragmentation and cell death J Immunol Methods 1991, 145:185-192 10.1016/0022-1759(91)90325-A 1765650
29. Miyauchi-Hashimoto H Sugihara A Tanaka K Horio T Ultraviolet radiation-induced impairment of tumor rejection is enhanced in xeroderma pigmentosum a gene-deficient mice J Invest Dermatol 2005, 124:1313-1317 10.1111/j.0022-202X.2005.23717.x 15955109
30. Matzinger P Bevan MJ Hypothesis: Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 1977, 29:1-5 10.1016/ 0008-8749(77)90269-6 300293
31. Melcher A Gough M Todryk S Vile R Apoptosis or necrosis for tumor immunotherapy: What's in a name? J Mol Med 1999, 77:824-833 10.1007/ s001099900066 10682318
32. Obeid M Tesniere A Ghiringhelli F Fimia GM Apetoh L Perfettini JL Castedo M Mignot G Panaretakis T Casares N Metivier D Larochette N van Endert P Ciccosanti F Piacentini M Zitvogel L Kroemer G Calreticulin exposure dictates the immunogenicity of cancer cell death Nat Med 2007, 13:54-61 10.1038/nm1523 17187072
33. Saas P Tiberghien P de Carvalho BM Cell-based therapy approaches using dying cells: From tumour immunotherapy to transplantation tolerance induction Expert Opin Biol Ther 2002, 2:249-263 10.1517/14712598.2.3.249 11890865
34. Zitvogel L Casares N Pequignot MO Chaput N Albert ML Kroemer G Immune response against dying tumor cells Adv Immunol 2004, 84:131-179 15246252
35. Kaplan DR Braciale VL Braciale TJ Antigen-dependent regulation of interleukin 2 receptor expression on cloned human cytotoxic T lymphocytes J Immunol 1984, 133:1966-1969 6206143
36. Ferrarini M Heltai S Zocchi MR Rugarli C Unusual expression and localization of heat-shock proteins in human tumor cells Int J Cancer 1992, 51:613-9 10.1002/ijc.2910510418 1601523
37. Multhoff G Botzler C Wiesnet M Muller E Meier T Wilmanns W Issels RD A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells Int J Cancer 1995, 61:272-9 10.1002/ijc.2910610222 7705958
38. Banerji U Walton M Raynaud F Grimshaw R Kelland L Valenti M Judson I Workman P Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models Clin Cancer Res 2005, 11:7023-7032 10.1158/1078-0432.CCR-05-0518 16203796
39. Clarke PA Hostein I Banerji U Stefano FD Maloney A Walton M Judson I Workman P Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone Oncogene 2000, 19:4125-4133 10.1038/sj.onc.1203753 10962573
40. Caricchio R Reap EA Cohen PL Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis J Immunol 1998, 161:241-251 9647230
41. Harada M Kimura G Nomoto K Heat shock proteins and the antitumor T cell response Biotherapy 1998, 10:229-235 10.1007/BF02678301 9559978
42. Li Z Srivastava PK Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation EMBO J 1993, 12:3143-3151 413580 8344253
43. Armstrong TD Pulaski BA Ostrand-Rosenberg S Tumor antigen presentation: changing the rules Cancer Immunol Immunother 1998 ,46:70-74 10.1007/ s002620050463 9558001
44. Mazzaferro V Coppa J Carrabba MG Rivoltini L Schiavo M Regalia E Mariani L Camerini T Marchiano A Andreola S Camerini R Corsi M Lewis JJ Srivastava PK Parmiani G Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer Clin Cancer Res 2003, 9:3235-3245 12960108
45. Brunet S Giacomoni PU Heat shock mRNA in mouse epidermis after UV irradiation Mutat Res 1989, 219:217-224 2770769
46. Caricchio R McPhie L Cohen PL Ultraviolet B radiation-induced cell death: Critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution J Immunol 2003, 171:5778-5786 14634086
47. Milazzo C Reichardt VL Muller MR Grunebach F Brossart P Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA Blood 2003, 101:977-982 10.1182/ blood-2002-04-1273 12393470
48. Parmiani G Castelli C Dalerba P Mortarini R Rivoltini L Marincola FM Anichini A Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going? J Natl Cancer Inst 2002, 94:805-818 12048268
49. Hadzantonis M O'Neill H Review: Dendritic cell immunotherapy for melanoma Cancer Biother Radiopharm 1999, 14:11-22 10850282
50. Ochsenbein AF Principles of tumor immunosurveillance and implications for immunotherapy Cancer Gene Ther 2002, 9:1043-1055 10.1038/ sj.cgt.7700540 12522443
51. Cheever MA Chen W Therapy with cultured T cells: Principles revisited Immunol Rev 1997, 157:177-194 10.1111/j.1600-065X.1997.tb00982.x 9255630